[{"Assets_0_Q3_USD":151533430.0,"CommonStockSharesOutstanding_0_Q3_shares":99046158.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-84112789.0,"NetIncomeLoss_1_Q3_USD":-23090693.0,"NetIncomeLoss_3_Q3_USD":-81697181.0,"StockholdersEquity_0_Q3_USD":33693570.0,"EarningsPerShareBasic_1_Q3_USD":-0.23,"EarningsPerShareBasic_3_Q3_USD":-0.83,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":99007985.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":98204375.0,"Ticker":"INO","CIK":"1055726","name":"INOVIO PHARMACEUTICALS, INC.","OfficialName":"Inovio Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"674206680.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20191112"}]